Charles River’s structural biology platform supports structure-based drug discovery from gene to final structures, including incorporation of your selected ligands. Our highly experienced staff employ the latest techniques and equipment and have expertise in:
High-throughput gene expression
Automated protein purification and crystallization
In addition, a range of biophysical techniques is available to accelerate and deepen the understanding of the interactions your ligand makes with its biological target.